Australia markets closed

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
57.98+2.08 (+3.72%)
At close: 04:00PM EDT
58.00 +0.02 (+0.03%)
After hours: 06:52PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.68B
Enterprise value 1.12B
Trailing P/E 3.75
Forward P/E 9.03
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.81
Price/book (mrq)1.29
Enterprise value/revenue 1.17
Enterprise value/EBITDA 1.79

Trading information

Stock price history

Beta (5Y monthly) 1.56
52-week change 3-16.26%
S&P500 52-week change 3-1.04%
52-week high 3112.00
52-week low 347.65
50-day moving average 357.67
200-day moving average 375.23

Share statistics

Avg vol (3-month) 3393.03k
Avg vol (10-day) 3421.43k
Shares outstanding 530.33M
Implied shares outstanding 6N/A
Float 820.38M
% held by insiders 129.40%
% held by institutions 141.19%
Shares short (12 May 2022) 41.72M
Short ratio (12 May 2022) 44.48
Short % of float (12 May 2022) 49.57%
Short % of shares outstanding (12 May 2022) 45.68%
Shares short (prior month 13 Apr 2022) 41.75M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 48.32%
Operating margin (ttm)64.71%

Management effectiveness

Return on assets (ttm)31.29%
Return on equity (ttm)43.42%

Income statement

Revenue (ttm)953.42M
Revenue per share (ttm)32.04
Quarterly revenue growth (yoy)-10.90%
Gross profit (ttm)777.05M
EBITDA 630.59M
Net income avi to common (ttm)460.65M
Diluted EPS (ttm)14.82
Quarterly earnings growth (yoy)-23.30%

Balance sheet

Total cash (mrq)585.11M
Total cash per share (mrq)19.29
Total debt (mrq)27.69M
Total debt/equity (mrq)2.11
Current ratio (mrq)5.40
Book value per share (mrq)43.07

Cash flow statement

Operating cash flow (ttm)493.81M
Levered free cash flow (ttm)408.6M